Reprogramming Autophagy to Strengthen Antitumour Immunity: Advances in Immunotherapeutic Strategies
Immunology · 2026
DOI: 10.1111/imm.70146 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology, 2026. Verfasst von Hamzeh J Al Ameer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Autophagy, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Autophagy is a central cellular process that supports homeostasis, yet it also plays a critical part in tumour immune evasion and treatment resistance, creating substantial obstacles for contemporary cancer immunotherapy. Because of this dual nature, targeted modulation of autophagy in either tumour cells or immune cells holds considerable potential to enhance therapeutic outcomes. However, the successful integration of autophagy directed strategies requires a clearer understanding of the molecular pathways through which autophagy shapes immune activity and treatment response. A more refined view of autophagy within the tumour immune microenvironment may open new therapeutic opportunities. Selectively targeting specific autophagy pathways could help overcome immune resistance and strengthen the impact of immunotherapy. Progress in this field will likely depend on the development of delivery systems that allow precise control of tumour autophagy in a compartment specific manner, as well as combination approaches that complement emerging treatments. Incorporating insights from immuno oncology, metabolic regulation, and immune surveillance may accelerate the translation of novel autophagy modulators into clinical testing, although current progress remains shaped largely by preclinical and early translational evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, India.
- Department of Anesthesia Techniques, Health and Medical Techniques College, Alnoor University, Mosul, Iraq.
- Department of Immunology, IMS and SUM Hospital, Siksha 'O' Anusandhan, Bhubaneswar, Odisha, India.
- University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.
- Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, India.
ORCID-Profile: Tashpulatov Tulkin, Abdullayeva Fazilat Arslanbekovna
Zitieren
APA
Al Ameer, H. J., Jyothi S, R., Ahmad, I. A., Patro, P. S., Arora, V., Singla, S., Tulkin, T., Arslanbekovna, A. F., & Kumar-Mishra, M. (2026). Reprogramming Autophagy to Strengthen Antitumour Immunity: Advances in Immunotherapeutic Strategies. Immunology. https://doi.org/10.1111/imm.70146
Vancouver
Al Ameer HJ, Jyothi S R, Ahmad IA, Patro PS, Arora V, Singla S, et al. Reprogramming Autophagy to Strengthen Antitumour Immunity: Advances in Immunotherapeutic Strategies. Immunology. 2026. doi:10.1111/imm.70146
BibTeX
@article{AlAmeer2026,
author = {Al Ameer, Hamzeh J and Jyothi S, Renuka and Ahmad, Israa Abdulhameed and Patro, Pradeepta Sekhar and Arora, Vimal and Singla, Siya and Tulkin, Tashpulatov and Arslanbekovna, Abdullayeva Fazilat and Kumar-Mishra, Manoj},
title = {Reprogramming Autophagy to Strengthen Antitumour Immunity: Advances in Immunotherapeutic Strategies},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70146}
}
EUVIMED